Get the Stockscreener App
247.18
0.58%
-1.43
After Hours:
247.18
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cardinal Health Inc stock is traded at $247.18, with a volume of 1.54M.
It is down -0.58% in the last 24 hours and up +5.84% over the past month.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
See More
Previous Close:
$248.61
Open:
$246.34
24h Volume:
1.54M
Relative Volume:
0.74
Market Cap:
$57.49B
Revenue:
$250.74B
Net Income/Loss:
$1.55B
P/E Ratio:
37.80
EPS:
6.5398
Net Cash Flow:
$4.39B
1W Performance:
+5.38%
1M Performance:
+5.84%
6M Performance:
+10.75%
1Y Performance:
+65.51%
1-Day Range:
$246.29
$249.29
1-Week Range:
$233.51
$249.29
52-Week Range:
$145.87
$258.30
Cardinal Health Inc Stock (CAH) Company Profile
Name
Cardinal Health Inc
Sector
Industry
Phone
(614) 757-3033
Address
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
247.18 | 53.13B | 250.74B | 1.55B | 4.39B | 6.5398 |
MCK
Mckesson Corp
|
907.99 | 97.79B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
330.95 | 60.05B | 328.68B | 2.55B | 1.56B | 13.03 |
HSIC
Henry Schein Inc
|
89.81 | 9.86B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
0.848 | 873.84M | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-05-25 | Upgrade | Jefferies | Hold → Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-06-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-13-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Upgrade | Argus | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Underweight |
| Jul-10-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-23 | Initiated | Citigroup | Neutral |
| Feb-03-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-04-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| May-26-22 | Downgrade | Barclays | Overweight → Equal Weight |
| May-18-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Apr-12-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Aug-06-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Underperform |
| May-10-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-21 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-25-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Jul-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-20-20 | Upgrade | BofA/Merrill | Underperform → Buy |
| Feb-12-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-16-19 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-27-19 | Downgrade | Argus | Buy → Hold |
| Aug-20-19 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-18-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-16-18 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Apr-02-18 | Upgrade | Argus | Hold → Buy |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Underperform |
| Jan-05-18 | Initiated | Evercore ISI | In-line |
View All
Cardinal Health Inc Stock (CAH) Latest News
Injectable Drug Delivery Market Forecast: USD 1,034.78 Billion by 2030 – MarketsandMarkets™ - Yahoo Finance
Cardinal Health stock gains on strong results and higher targets - AD HOC NEWS
Nagaraj Bhat Appointed Vice President/GM, Global Capability Center (GCC) Site Leader at DePuy Synthes - hrtoday.in
Cardinal Health stock holds firm as investors digest strong earnings and guidance - AD HOC NEWS
Is CAH Becoming the Backbone of US Healthcare Infrastructure? - Eastern Progress
Chicago Archbishop Cardinal Blase Cupich, 2 orders of Catholic nuns file lawsuit in effort to block IL medical aid-in-dying law - ABC7 Chicago
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - Currently.com
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Cencora (COR) Unveils Cell And Gene Therapy Enablement Service - simplywall.st
Cardinal Health leases Sacramento building for 100-job distribution center - The Business Journals
Jim Cramer Makes Bold Cardinal Health (NYSE: CAH) Claim As Specialty Push Drives Earnings Growth - foreignpolicyjournal.com
Jim Cramer Notes Cardinal Health (CAH) is “Too Attractive to Ignore” - Yahoo Finance
Cardinal Health Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen - Yahoo Finance
Is Generics Still a Quiet Profit Engine for Cardinal Health? - Yahoo Finance
Cardinal Health (CAH) Advances 2.57% to $245.49, Edging Toward Key Resistance at $257.76Risk Reward Setups - dars.gov.et
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health stock gains support from strong cash flow and dividend - AD HOC NEWS
Cardinal Health stock edges higher as investors eye FY 2027 guidance - AD HOC NEWS
Cardinal Health stock holds steady as consensus price targets point higher - AD HOC NEWS
Precision Trading with Cardinal Health Inc. (CAH) Risk Zones - Stock Traders Daily
Cardinal Health Inc. stock outperforms competitors despite losses on the day - MarketWatch
What Cardinal Health (CAH)'s Bigger Buyback, Dividend and New Credit Line Means For Shareholders - sahmcapital.com
Trade Alert: CEO & Director Of Cardinal Health Jason Hollar Has Sold Stock - simplywall.st
The CIO of Cardinal Health Parted With 11,650 Shares. Here's Whether It Matters for Long-Term Investors - The Motley Fool
Cardinal Health CEO Sells $29 Million in Stock After Earnings Send Shares to Record - Barron's
Paralel Advisors LLC Invests $2.60 Million in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Updates Labeling for Leader Dry Eye Relief Eye Drops - geneonline.com
118,900 Shares in Cardinal Health, Inc. $CAH Bought by Ceredex Value Advisors LLC - MarketBeat
Cardinal Health stock holds firm after August 11 earnings - Ad-hoc-news.de
Great Lakes Advisors LLC Makes New $3.65 Million Investment in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health CEO Jason Hollar sells $29.4m in company stock - Investing.com South Africa
Cardinal Health Chief Accounting Officer Mary C. Scherer Sells 2,302 Shares in August 2026 - Kalkine Media
Cardinal Health (NYSE:CAH) CAO Sells 2,302 Shares of Stock - MarketBeat
Cardinal Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Cardinal Health stock holds close to record levels as insider sales and analyst targets frame the ne - Ad-hoc-news.de
Cardinal Health CEO Deborah Weitzman sells $1.73m in shares By Investing.com - Investing.com South Africa
Cardinal Health (CAH) CEO Jason Hollar Sells 124,529 Shares - GuruFocus
Cardinal Health PSS Segment CEO Deborah Weitzman Sells 7,354 Shares in August 2026 Transactions - Kalkine Media
Cardinal Health chief legal officer Jessica Mayer sells $6.95m in stock - Investing.com South Africa
Cardinal Health (NYSE:CAH) Insider Michelle Greene Sells 11,650 Shares - MarketBeat
Cardinal Health CFO Aaron Alt sells $9.9 million in shares By Investing.com - Investing.com South Africa
Cardinal Health CIO Greene sells $2.75m in stock By Investing.com - Investing.com South Africa
Cardinal Health CEO, GMPD segment Mason sells $8.27m shares - Investing.com
Cardinal Health CEO, GMPD segment Mason sells $8.27m shares By Investing.com - Investing.com India
Cardinal Health (CAH) Taps Anita Zielinski As Chief Accounting Officer - Sahm
Cardinal Health (CAH) insider sells 35K shares; no 10b5-1 plan noted - Stock Titan
Cardinal Health Insiders Sold Shares Worth Over $9.7M - TradingView
Cardinal Health (NYSE:CAH) Upgraded to "Moderate Buy" at Royal Bank Of Canada - MarketBeat
6,085 Shares in Cardinal Health, Inc. $CAH Acquired by Meeder Advisory Services Inc. - MarketBeat
4,464 Shares in Cardinal Health, Inc. $CAH Acquired by First National Bank of Omaha - MarketBeat
Cardinal Health Inc Stock (CAH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):